Diligence memo · auto-generated · as of July 2, 2026

Precision Dermatology, Inc.

Precision Dermatology, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Precision Dermatology, Inc. operates in Other Health Care, based in CUMBERLAND.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Precision Dermatology, Inc. has raised $103M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $55M on 2012-04-25.

Most recent recorded round closed around 2012-04-25.

Valuation (modeled)modeled

Provath models Precision Dermatology, Inc. at approximately $1.3B (range $200M–$3.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.07× the median modeled value of Series C Other Health Care companies in 2010–2012 (24 peers) — value vs value, same stage and era. Within the normal band (107% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 9 months.

Last raise 14.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.9× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Other Health Care peers (5377 compared).

Modeled value ranks above 98% of those peers.

Closest niche peers: Castlight Health, Inc., Msd Parent Corp., Pentec Healthcare Infusions, Inc., OraPharma Topco Holdings, Inc., Cameron Health, Inc..

Peoplefiled

18 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.